MedGenome and Emmes launch strategic partnership focussed on advancing rare disease research Read more
The future CRO/CDMO will offer end-to-end solutions and operate as a large pharma or biotech company Read more
Veeda Clinical Research receives growth capital from Sabre Partners and a group of marquee HNIs Read more
